臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"chiun hsu"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 211-260 / 356 (共8页)
<< < 1 2 3 4 5 6 7 8 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2020-04-10T12:51:22Z	Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapy	Wei S.-C.; Cheng A.-L.; Chen P.-J.; Chiun Hsu
臺大學術典藏	2020-04-10T12:51:22Z	Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival	Cheng A.-L.; Shen Y.-C.; Hu F.-C.; Jeng Y.-M.; Chang Y.-T.; Lin Z.-Z.; Chang M.-C.; Chiun Hsu
臺大學術典藏	2020-04-10T12:51:22Z	Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial	Huang T.-C.; Yang P.-C.; Yang C.-H.; Lin C.-C.; Chiun Hsu; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2020-04-10T12:51:22Z	Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer	Chang Y.-T.;Chang M.-C.;Wei S.-C.;Tien Y.-W.;Chiun Hsu;Liang P.-C.;Tsao P.-N.;Jan I.-S.;Wong J.-M.; Chang Y.-T.; Chang M.-C.; Wei S.-C.; Tien Y.-W.; Chiun Hsu; Liang P.-C.; Tsao P.-N.; Jan I.-S.; Wong J.-M.
臺大學術典藏	2020-04-10T12:51:21Z	Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma	Ou D.-L.; Shen Y.-C.; Liang J.-D.; Liou J.-Y.; Yu S.-L.; Fan H.-H.; Wang D.-S.; Lu Y.-S.; Chiun Hsu; Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:21Z	Lamivudine and hepatitis B reactivation	Chiun Hsu; Cheng A.-L.; Chen P.-J.
臺大學術典藏	2020-04-10T12:51:21Z	Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway	Chen K.-F.; Yeh P.-Y.; Chiun Hsu; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; Chen P.-J.; Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:21Z	The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma	Lin Z.-Z.;Hsu H.-C.;Hsu C.-H.;Yeh P.-Y.;Huang C.-Y.F.;Huang Y.-F.;Chen T.-J.;Kuo S.-H.;Chiun Hsu;Hu F.-C.;Jeng Y.-M.;Chung Y.;Cheng A.-L.; Lin Z.-Z.; Hsu H.-C.; Hsu C.-H.; Yeh P.-Y.; Huang C.-Y.F.; Huang Y.-F.; Chen T.-J.; Kuo S.-H.; Chiun Hsu; Hu F.-C.; Jeng Y.-M.; Chung Y.; Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:20Z	Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: Experts'opinion	Yeo W.; Yeoh E.-M.; Furuse J.; Han K.-H.; Chiun Hsu; Lim H.-Y.; Moon H.; Qin S.; Ye S.-L.; Chen P.-J.; Chen P.-J.;Furuse J.;Han K.-H.;Chiun Hsu;Lim H.-Y.;Moon H.;Qin S.;Ye S.-L.;Yeoh E.-M.;Yeo W.
臺大學術典藏	2020-04-10T12:51:20Z	Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma	Hsu C.-H.;Yang T.-S.;Chiun Hsu;Toh H.C.;Epstein R.J.;Hsiao L.-T.;Chen P.-J.;Lin Z.-Z.;Chao T.-Y.;Cheng A.-L.; Hsu C.-H.; Yang T.-S.; Chiun Hsu; Toh H.C.; Epstein R.J.; Hsiao L.-T.; Chen P.-J.; Lin Z.-Z.; Chao T.-Y.; Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:20Z	Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B	Ko B.-S.;Chang T.-C.;Chen C.-H.;Liu C.-C.;Kuo C.-C.;Chiun Hsu;Shen Y.-C.;Shen T.-L.;Golubovskaya V.M.;Chang C.-C.;Shyue S.-K.;Liou J.-Y.; Ko B.-S.; Chang T.-C.; Chen C.-H.; Liu C.-C.; Kuo C.-C.; Chiun Hsu; Shen Y.-C.; Shen T.-L.; Golubovskaya V.M.; Chang C.-C.; Shyue S.-K.; Liou J.-Y.
臺大學術典藏	2020-04-10T12:51:19Z	Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma	Hsu C.-H.;Shen Y.-C.;Lin Z.-Z.;Chen P.-J.;Shao Y.-Y.;Ding Y.-H.;Chiun Hsu;Cheng A.-L.; Hsu C.-H.; Shen Y.-C.; Lin Z.-Z.; Chen P.-J.; Shao Y.-Y.; Ding Y.-H.; Chiun Hsu; Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:18Z	Clinical Development and Future Direction for the Treatment of Hepatocellular Carcinoma	Whang-Peng J.;Cheng A.-L.;Chiun Hsu;Chen C.-M.; Whang-Peng J.; Cheng A.-L.; Chiun Hsu; Chen C.-M.
臺大學術典藏	2020-04-10T12:51:18Z	Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach	Cheng A.-L.; Hu F.-C.; Cheng C.-C.; Chen L.-T.; Chiun Hsu; Shen Y.-C.; Shen Y.-C.;Chiun Hsu;Chen L.-T.;Cheng C.-C.;Hu F.-C.;Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:18Z	Geographic difference in survival outcome for advanced hepatocellular carcinoma: Implications on future clinical trial design	Chiun Hsu; Shen Y.-C.; Cheng C.-C.; Hu F.-C.; Cheng A.-L.; Chiun Hsu;Shen Y.-C.;Cheng C.-C.;Hu F.-C.;Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:17Z	Overexpression of 14-3-3ε predicts tumour metastasis and poor survival in hepatocellular carcinoma	Liou J.-Y.; Ko B.-S.; Chang T.-C.; Chiun Hsu; Chen Y.-C.; Shen T.-L.; Chen S.-C.; Wang J.; Wu K.K.; Jan Y.-J.; Ko B.-S. ;Chang T.-C. ;Chiun Hsu ;Chen Y.-C. ;Shen T.-L. ;Chen S.-C. ;Wang J. ;Wu K.K. ;Jan Y.-J. ;Liou J.-Y.
臺大學術典藏	2020-04-10T12:51:17Z	Eastern asian expert panel opinion: Designing clinical trials of molecular targeted therapy for hepatocellular carcinoma	Yeo W.;Chen P.-J.;Furuse J.;Han K.-H.;Chiun Hsu;Lim H.-Y.;Moon H.;Qin S.;Yeoh E.-M.;Ye S.-L.; Yeo W.; Chen P.-J.; Furuse J.; Han K.-H.; Chiun Hsu; Lim H.-Y.; Moon H.; Qin S.; Yeoh E.-M.; Ye S.-L.
臺大學術典藏	2020-04-10T12:51:17Z	Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma	Shao Y.-Y.;Lin Z.-Z.;Chiun Hsu;Shen Y.-C.;Hsu C.-H.;Cheng A.-L.; Shao Y.-Y.; Lin Z.-Z.; Chiun Hsu; Shen Y.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:17Z	Induction of DNA damage-inducible gene GADD45β contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells	Shen Y.-C.; Ou D.-L.; Ou D.-L.;Shen Y.-C.;Yu S.-L.;Chen K.-F.;Yeh P.-Y.;Fan H.-H.;Feng W.-C.;Wang C.-T.;Lin L.-I.;Chiun Hsu;Cheng A.-L.; Cheng A.-L.; Yeh P.-Y.; Fan H.-H.; Feng W.-C.; Wang C.-T.; Lin L.-I.; Chiun Hsu; Chen K.-F.; Yu S.-L.
臺大學術典藏	2020-04-10T12:51:16Z	High circulating endothelial progenitor levels associated with poor survival of advanced hepatocellular carcinoma patients receiving sorafenib combined with metronomic chemotherapy	Shao Y.-Y. ;Lin Z.-Z. ;Chen T.-J. ;Chiun Hsu ;Shen Y.-C. ;Hsu C.-H. ;Cheng A.-L.; Shao Y.-Y.; Lin Z.-Z.; Chen T.-J.; Chiun Hsu; Shen Y.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:16Z	Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil	Hsu C.-H.; Hu F.-C.; Hsu C.-Y. ;Shen Y.-C. ;Yu C.-W. ;Chiun Hsu ;Hu F.-C. ;Hsu C.-H. ;Chen B.-B. ;Wei S.-Y. ;Cheng A.-L. ;Shih T.T.-F.; Hsu C.-Y.; Shen Y.-C.; Yu C.-W.; Chiun Hsu; Chen B.-B.; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F.
臺大學術典藏	2020-04-10T12:51:16Z	Diagnostic value of 18F-FDG-PET/CT in indeterminate infiltrative hepatic lesions in an endemic area of viral hepatitis	Chiun Hsu; Chang Y.-T.; Tzen K.-Y.; Wang H.-P.; Wu Y.-M.; Cheng M.-F. ;Wu Y.-W. ;Liu K.-L. ;Yen R.-F. ;Wu Y.-M. ;Chiun Hsu ;Chang Y.-T. ;Tzen K.-Y. ;Wang H.-P.; Cheng M.-F.; Wu Y.-W.; Liu K.-L.; Yen R.-F.
臺大學術典藏	2020-04-10T12:51:15Z	Phase II study of concomitant thalidomide during radiotherapy for hepatocellular carcinoma	Ch'Ang H.-J.; Chiun Hsu; Chen C.-H.; Chang Y.-H.; Chang J.S.; Chen L.-T.
臺大學術典藏	2020-04-10T12:51:15Z	End-of-life care for cancer patients in Taiwan	Chiun Hsu
臺大學術典藏	2020-04-10T12:51:15Z	Antiangiogenic strategies for the treatment of hepatocellular carcinoma	Chiun Hsu; Shen Y.-C.; Cheng A.-L.; Chiun Hsu ;Shen Y.-C. ;Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:15Z	Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials	Yang S.-H.; Kuo Y.-H.; Tien Y.-W.; Chiun Hsu; Hsu C.-H.; Kuo S.-H.; Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:15Z	Increased expression of 14-3-3β promotes tumor progression and predicts extrahepatic metastasis and worse survival in hepatocellular carcinoma	Liu T.-A.; Liu T.-A. ;Jan Y.-J. ;Ko B.-S. ;Chen S.-C. ;Liang S.-M. ;Hung Y.-L. ;Chiun Hsu ;Shen T.-L. ;Lee Y.-M. ;Chen P.-F. ;Wang J. ;Shyue S.-K. ;Liou J.-Y.; Jan Y.-J.; Ko B.-S.; Chen S.-C.; Liang S.-M.; Hung Y.-L.; Chiun Hsu; Shen T.-L.; Lee Y.-M.; Chen P.-F.; Wang J.; Shyue S.-K.; Liou J.-Y.
臺大學術典藏	2020-04-10T12:51:15Z	Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma	Cheng A.-L.; Hsu C.-H.; Lin Z.-Z.; Chiun Hsu; Lee K.-D.; Hsiao C.-H.; Lu Y.-S.; Huang C.-C.; Shen Y.-C.; Shao Y.-Y.
臺大學術典藏	2020-04-10T12:51:14Z	Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression	Chiun Hsu; Shen Y.-C.; Cheng C.-C.; Cheng A.-L.; Hu F.-C.; Yeh K.-H.
臺大學術典藏	2020-04-10T12:51:14Z	Factors impacting prognosis prediction in BCLC stage C and Child-Pugh Class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy	Lin Z.-Z.; Chiun Hsu; Hu F.-C.; Shao Y.-Y.; Chang D.-Y.; Yang C.-H.; Hong R.-L.; Hsu C.-H.; Chengb A.-L.
臺大學術典藏	2020-04-10T12:51:14Z	A critical evaluation of the preventive effect of antiviral therapy on the development of hepatocellular carcinoma in patients with chronic hepatitis C or B: A novel approach by using meta-regression	Shen Y.-C.; Chiun Hsu; Cheng C.-C.; Hu F.-C.; Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:14Z	Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study	Chiun Hsu;Yang T.-S.;Huo T.-I.;Hsieh R.-K.;Yu C.-W.;Hwang W.-S.;Hsieh T.-Y.;Huang W.-T.;Chao Y.;Meng R.;Cheng A.-L.; Chiun Hsu; Yang T.-S.; Huo T.-I.; Hsieh R.-K.; Yu C.-W.; Hwang W.-S.; Hsieh T.-Y.; Huang W.-T.; Chao Y.; Meng R.; Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:13Z	The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines	Chen W.-W.; Chang D.-Y.; Huang S.-M.; Lin C.-H.; Chiun Hsu; Lin M.-H.; Huang C.-S.; Lu Y.-S.; Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:13Z	Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy	Kuo Y.-H.; Lin C.-H.; Shau W.-Y.; Chen T.-J.; Yang S.-H.; Huang S.-M.; Chiun Hsu; Lu Y.-S.; Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:13Z	Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems	Shao Y.-Y.; Lu L.-C.; Lin Z.-Z.; Chiun Hsu; Shen Y.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:13Z	Comparative microRNA detection from precursor-microRNA-transfected hepatocellular carcinoma cells by capillary electrophoresis with dual-color laser-induced fluorescence	Ou D.-L.; Chiun Hsu; Huang S.-H.; Chang P.-L.; Yang T.-H.
臺大學術典藏	2020-04-10T12:51:13Z	Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer	Cheng A.-L.; Yeh K.-H.; Chiun Hsu; Cheng W.-F.; Lin Y.-L.; Lu L.-C.; Shao Y.-Y.; Hsu C.-H.
臺大學術典藏	2020-04-10T12:51:12Z	14-3-3ε Overexpression Contributes to Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma	Wang J.; Chiun Hsu; Wu Y.-M.; Liou J.-Y.; Chen S.-C.; Liang S.-M.; Liu T.-A.; Jan Y.-J.; Ko B.-S.
臺大學術典藏	2020-04-10T12:51:12Z	Erratum: Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression (Gastric Cancer (2012) 15(265-280) DOI 10.1007/s10120-011- 0106-5)	Chiun Hsu; Shen Y.-C.; Cheng C.-C.; Cheng A.-L.; Hu F.-C.; Yeh K.-H.
臺大學術典藏	2020-04-10T12:51:12Z	Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients	Chen I.C.; Chiun Hsu; Chen Y.C.; Chien S.F.; Kao H.F.; Chang S.Y.; Hu F.C.; Yeh K.H.
臺大學術典藏	2020-04-10T12:51:12Z	Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma	Shen Y.-C.; Ou D.-L.; Chiun Hsu; Lin K.-L.; Chang C.-Y.; Lin C.-Y.; Liu S.-H.; Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:11Z	A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy	Shao Y.-Y.; Liang P.-C.; Wu Y.-M.; Huang C.-C.; Huang K.-W.; Cheng J.C.; Hsu C.-H.; Chiun Hsu; Cheng A.-L.; Lin Z.-Z.
臺大學術典藏	2020-04-10T12:51:11Z	Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study	Hsu C.-H.; Kang Y.K.; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.; Jin K.; Chiun Hsu; Cheng A.-L.; Yang T.-S.; Shun C.-T.; Shao Y.-Y.
臺大學術典藏	2020-04-10T12:51:11Z	Potentiating the Efficacy of Molecular Targeted Therapy for Hepatocellular Carcinoma by Inhibiting the Insulin-Like Growth Factor Pathway	Ou D.-L.; Lee B.-S.; Chang Y.-C.; Lin L.-I.; Liou J.-Y.; Chiun Hsu; Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:10Z	Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer	Su W.-C.; Chao Y.; Yeh K.-H.; Cheng A.-L.; Chen L.-T.; Lin Z.-Z.; Shen Y.-C.; Li C.-P.; Yen C.-J.; Chiun Hsu; Lin Y.-L.; Shen Y.-C.;Li C.-P.;Yen C.-J.;Chiun Hsu;Lin Y.-L.;Lin Z.-Z.;Chen L.-T.;Su W.-C.;Chao Y.;Yeh K.-H.;Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:10Z	Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study	Chiun Hsu; Tsou H.-H.; Lin S.-J.; Wang M.-C.; Yao M.; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.; Chang C.-S.; Tien H.-F.; Liu T.-W.; Chen P.-J.; Cheng A.-L.
臺大學術典藏	2020-04-10T12:51:10Z	Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size	Lin Z.-Z.; Shau W.-Y.; Chiun Hsu; Shao Y.-Y.; Yeh Y.-C.; Kuo R.N.-C.; Hsu C.-H.; Yang J.C.-H.; Cheng A.-L.; Lai M.-S.
臺大學術典藏	2020-04-10T12:51:10Z	Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group	Cheng A.-L.; Lim S.T.; Suh C.; Kwong Y.-L.; Kim W.S.; Chng W.-J.; Kim S.J.; Chiun Hsu; Song Y.-Q.; Tay K.; Hong X.-N.; Cao J.; Kim J.S.; Eom H.S.; Lee J.H.; Zhu J.; Chang K.-M.; Reksodiputro A.H.; Tan D.; Goh Y.T.; Lee J.; Intragumtornchai T.
臺大學術典藏	2020-04-10T12:51:09Z	Clinicopathological and prognostic significances of EGFR, KRAS and BRAF mutations in biliary tract carcinomas in Taiwan	Chang Y.-T.; Chang M.-C.; Huang K.-W.; Tung C.-C.; Chiun Hsu; Wong J.-M.
臺大學術典藏	2020-04-10T12:51:09Z	Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers	Kao H.-F.;Chen I.-C.;Chiun Hsu;Chang S.-Y.;Chien S.-F.;Chen Y.-C.;Hu F.-C.;Yang J.C.-H.;Cheng A.-L.;Yeh K.-H.; Kao H.-F.; Chen I.-C.; Chiun Hsu; Chang S.-Y.; Chien S.-F.; Chen Y.-C.; Hu F.-C.; Yang J.C.-H.; Cheng A.-L.; Yeh K.-H.

显示项目 211-260 / 356 (共8页)
<< < 1 2 3 4 5 6 7 8 > >>
每页显示[10|25|50]项目

	English \| 正體中文 \| 简体中文 \| 总笔数 :0
	造访人次 : 52880177 在线人数 : 678 教育部委托研究计画计画执行:国立台湾大学图书馆